| Name | Title | Contact Details |
|---|
Technology that moves the world. Sabre is a leading technology solutions provider to the nearly US$8 trillion travel industry. Our technology and data-driven solutions help our airline, hotel and travel agency customers grow their businesses and transform the traveler experience. The scale, breadth and depth of our technology is unmatched and sustains a complex industry. We provide an open and stable platform to deliver flexible, reliable and scalable solutions. Over the years, we have shaped and modernized the travel industry. We pioneered online travel agencies, corporate booking tools, revenue management, and web and mobile itinerary tools, to name a few. Sabre offers the travel industry`s broadest range of technology solutions including data-driven business intelligence, mobile, distribution and Software as a Service (SaaS) solutions, used by travel suppliers and buyers to plan, market, sell, serve and operate their businesses. Our travel marketplace transacts more than US$120 billion of travel spend per year. And we are the world`s largest provider of airline and hotel technology. We have been named to the InformationWeek 500 list of the most innovative technology companies for 11 consecutive years. And InformationWeek named Sabre seventh on its list of the “Greatest Software Ever Written.”
Lockheed Mrtin Dsktop Slutions is a Washington, DC-based company in the Software and Internet sector.
Quality Systems, Inc. ("QSI") and its wholly-owned subsidiary, NextGen Healthcare Information Systems, Inc. ("NextGen"), develop and provide computer-based practice management, medical records, and e-business applications for medical and dental group practices. The QSI and NextGen divisions have built strong positions in the large practice markets in both the medical and dental arenas. The company derives most of its revenue and growth from the emerging EMR marketplace, its P3 connectivity suite, and its high functionality practice management suites. QSI is conservatively managed from a financial perspective and concurrently maintains a strategy of aggressive reinvestment in new product and service development initiatives.
Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.
Founded in 2000, Steelwedge pioneered and leads the market for integrated business planning solutions, uniting demand, supply and financial forecasts for a clear line of sight from plan to performance to profit. Leading global enterprises trust Steelwedge`s cloud-based solution to deliver ”what-if” scenario modeling and real-time insight on supply-demand trade-offs they need to compete in today`s highly competitive, complex and volatile global business environment.